SFM
Sphera Funds Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-7,000
| Closed | -$1.93M | – | 107 |
|
|
2024
Q3 | $1.93M | Buy |
+7,000
| New | +$1.93M | 0.31% | 81 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 111 |
|
|
2024
Q1 | – | Sell |
-36,230
| Closed | -$6.93M | – | 94 |
|
|
2023
Q4 | $6.93M | Buy |
36,230
+129
| +0.4% | +$24.7K | 1.12% | 31 |
|
|
2023
Q3 | $6.39M | Sell |
36,101
-3,899
| -10% | -$691K | 1.16% | 25 |
|
|
2023
Q2 | $7.6M | Buy |
+40,000
| New | +$7.6M | 1.19% | 18 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 67 |
|
|
2022
Q2 | – | Sell |
-24,768
| Closed | -$4.04M | – | 51 |
|
|
2022
Q1 | $4.04M | Buy |
+24,768
| New | +$4.04M | 0.57% | 36 |
|
|
2018
Q4 | – | Sell |
-40,000
| Closed | -$3.5M | – | 101 |
|
|
2018
Q3 | $3.5M | Sell |
40,000
-155,232
| -80% | -$13.6M | 0.4% | 73 |
|
|
2018
Q2 | $19.2M | Buy |
+195,232
| New | +$19.2M | 2.65% | 7 |
|
|
2017
Q3 | – | Sell |
-50,000
| Closed | -$3.99M | – | 122 |
|
|
2017
Q2 | $3.99M | Buy |
+50,000
| New | +$3.99M | 0.68% | 41 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 105 |
|
|
2016
Q2 | – | Sell |
-70,000
| Closed | -$4.39M | – | 87 |
|
|
2016
Q1 | $4.39M | Buy |
70,000
+30,000
| +75% | +$1.88M | 0.95% | 13 |
|
|
2015
Q4 | $3.77M | Hold |
40,000
| – | – | 0.55% | 30 |
|
|
2015
Q3 | $3.21M | Buy |
40,000
+3,000
| +8% | +$241K | 0.41% | 42 |
|
|
2015
Q2 | $4.44M | Buy |
+37,000
| New | +$4.44M | 0.43% | 45 |
|